2,515
Views
4
CrossRef citations to date
0
Altmetric
Coronavirus – Case Report

Miller-Fisher syndrome and Guillain–Barre syndrome overlap syndrome following inactivated COVID-19 vaccine: Case report and scope review

, , , , ORCID Icon &
Article: 2125753 | Received 14 Aug 2022, Accepted 14 Sep 2022, Published online: 31 Oct 2022

References

  • Shahrizaila N, Lehmann HC, Kuwabara S. Guillain-Barre syndrome. Lancet. 2021;397:1–5. doi:10.1016/S0140-6736(21)00517-1.
  • Sejvar JJ, Kohl KS, Gidudu J, Amato A, Bakshi N, Baxter R, Burwen DR, Cornblath DR, Cleerbout J, Edwards KM, et al. 2011. Guillain-Barre syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine. 29:599–612. doi:10.1016/j.vaccine.2010.06.003.
  • van den Berg B, Walgaard C, Drenthen J, Fokke C, Jacobs BC, van Doorn PA. Guillain-Barre syndrome: pathogenesis, diagnosis, treatment and prognosis. Nat Rev Neurol. 2014;10:469–82. doi:10.1038/nrneurol.2014.121.
  • Yuki N, Kuwabara S. Axonal Guillain-Barre syndrome: carbohydrate mimicry and pathophysiology. J Peripher Nerv Syst. 2007;12:238–49. doi:10.1111/j.1529-8027.2007.00153.x.
  • Assiri SA, Althaqafi RMM, Alswat K, Alghamdi AA, Alomairi NE, Nemenqani DM, Ibrahim ZS, Elkady A. Post COVID-19 vaccination-associated neurological complications. Neuropsychiatr Dis Treat. 2022;18:137–54. doi:10.2147/NDT.S343438.
  • Dang YL, Bryson A. Miller-Fisher syndrome and Guillain-Barre syndrome overlap syndrome in a patient post Oxford-AstraZeneca SARS-CoV-2 vaccination. BMJ Case Rep. 2021;14:e246701. doi:10.1136/bcr-2021-246701.
  • Nishiguchi Y, Matsuyama H, Maeda K, Shindo A, Tomimoto H. Miller Fisher syndrome following BNT162b2 mRNA coronavirus 2019 vaccination. BMC Neurol. 2021;21:452. doi:10.1186/s12883-021-02489-x.
  • Kim JE, Park J, Min YG, Hong YH, Song TJ. Associations of Guillain-Barré syndrome with coronavirus disease 2019 vaccination: disproportionality analysis using the World Health Organization pharmacovigilance database. J Peripher Nerv Syst. 2022;27:206–14. doi:10.1111/jns.12507.
  • Parida SP, Sahu DP, Singh AK, Alekhya G, Subba SH, Mishra A, Padhy BM, Patro BK. Adverse events following immunization of COVID-19 (Covaxin) vaccine at a tertiary care center of India. J Med Virol. 2022;94:2453–59. doi:10.1002/jmv.27655.
  • Tamborska AA, Singh B, Leonhard SE, Hodel EM, Stowe J, Watson-Fargie T, Fernandes PM, Themistocleous AC, Roelofs J, Brennan K, et al. 2022. Guillain-Barre syndrome following SARS-CoV-2 vaccination in the UK: a prospective surveillance study. BMJ Neurol Open. 4:e000309. doi:10.1136/bmjno-2022-000309.
  • Garcia-Grimshaw M, Michel-Chavez A, Vera-Zertuche JM, Galnares-Olalde JA, Hernandez-Vanegas LE, Figueroa-Cucurachi M, Paredes-Ceballos O, Reyes-Teran G, Carbajal-Sandoval G, Ceballos-Liceaga SE, et al. 2021. Guillain-Barre syndrome is infrequent among recipients of the BNT162b2 mRNA COVID-19 vaccine. Clin Immunol. 230:108818. doi:10.1016/j.clim.2021.108818.
  • Yamakawa M, Nakahara K, Nakanishi T, Nomura T, Ueda M. Miller Fisher syndrome following vaccination against SARS-CoV-2. Intern Med. 2022;61:1067–69. doi:10.2169/internalmedicine.8851-21.
  • Abicic A, Adamec I, Habek M. Miller Fisher syndrome following Pfizer COVID-19 vaccine. Neurol Sci. 2022;43:1495–97. doi:10.1007/s10072-021-05776-0.
  • Kim JE, Min YG, Shin JY, Kwon YN, Bae JS, Sung JJ, Hong YH. Guillain-Barre syndrome and variants following COVID-19 vaccination: report of 13 cases. Front Neurol. 2021;12:820723. doi:10.3389/fneur.2021.820723.
  • Kubota T, Hasegawa T, Ikeda K, Aoki M. Case report: isolated, unilateral oculomotor palsy with anti-GQ1b antibody following COVID-19 vaccination. F1000res. 2021;10:1142. doi:10.12688/f1000research.74299.1.
  • Siddiqi AR, Khan T, Tahir MJ, Asghar MS, Islam MS, Yousaf Z. Miller Fisher syndrome after COVID-19 vaccination: case report and review of literature. Medicine (Baltimore). 2022;101:e29333. doi:10.1097/MD.0000000000029333.
  • Michaelson NM, Lam T, Malhotra A, Schiff ND, MacGowan DJL. Miller Fisher syndrome presenting after a second dose of Pfizer-BioNtecH vaccination in a patient with resolved COVID-19: a case report. J Clin Neuromuscul Dis. 2021;23:113–15. doi:10.1097/CND.0000000000000376.
  • Chiba A, Kusunoki S, Obata H, Machinami R, Kanazawa I. Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barre syndrome: clinical and immunohistochemical studies. Neurology. 1993;43:1911–17. doi:10.1212/WNL.43.10.1911.
  • Salmon DA, Proschan M, Forshee R, Gargiullo P, Bleser W, Burwen DR, Cunningham F, Garman P, Greene SK, Lee GM, et al. 2013. Association between Guillain-Barre syndrome and influenza a (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis. Lancet. 381:1461–68. doi:10.1016/S0140-6736(12)62189-8.
  • Prestel J, Volkers P, Mentzer D, Lehmann HC, Hartung HP, Keller-Stanislawski B; Group GBSSRisk of Guillain-Barre syndrome following pandemic influenza A(H1N1) 2009 vaccination in Germany. Pharmacoepidemiol Drug Saf. 2014;23:1192–204. doi:10.1002/pds.3638.